Clinical Trials Browser

Phase 2 × ixazomib × Genitourinary × Clear all

NCT03587662 2026-01-09

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Phase 2 Active not recruiting

Carcinoma, Renal Cell